Prognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy
- 1Division of Nephrology, Department of Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
- 2Department of Pathology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea
Abstract
Objective: The prognostic nutritional index (PNI) reflects immunonutritional status and serves as a prognostic marker in various diseases. However, its clinical significance in IgA nephropathy (IgAN) remains poorly understood. We investigated the association between PNI and clinico-pathological severity as well as long-term kidney outcomes in IgAN.
Methods: We retrospectively analyzed 153 patients with biopsy-proven IgAN. Patients were categorized into four PNI groups (<40, 40–50 [reference], 50–55, and ≥55). The primary outcome was urine protein-to-creatinine ratio (UPCR) at biopsy; secondary outcomes were pathological severity (Oxford MEST-C and Haas classifications) and a composite kidney outcome (creatinine doubling, ≥40% eGFR decline, or dialysis initiation).
Results: In the fully adjusted models, the lowest PNI group (<40) exhibited a 3.49-fold higher UPCR (AMR 3.49; p < 0.001) and was independently associated with segmental sclerosis (S1) (OR 5.09; p=0.029) and crescents (C1/2) (OR 3.81; p=0.031). Conversely, the highest PNI group (≥55) showed lower UPCR (AMR 0.47; p<0.001), reduced risk of advanced tubular atrophy/interstitial fibrosis (T1/2) (OR 0.31; p=0.042), and lower Haas stages (OR 0.29; p=0.010). Although the association with long-term outcomes was attenuated after UPCR adjustment in the total cohort, the lowest PNI group maintained a highly significant risk among patients with non-nephrotic range proteinuria (HR 17.99; p=0.006).
Conclusion: PNI was associated with proteinuria and histological severity in IgAN and may provide additional prognostic information for long-term kidney outcomes beyond proteinuria alone, particularly in patients with non-nephrotic-range proteinuria.
Related
- Computed tomography-based measurements of fat quality are associated with the prognostic nutritional index in gastric cancer patients
- Clinical impact of the prognostic nutritional index at listing and immediately before surgery in lung transplantation
- Clinical Impact of Prognostic Immune and Nutritional Index on Short- and Long-term Outcomes of Older Patients with Colorectal Cancer.
- HIV‐associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise
- Pretreatment Prognostic Nutritional Index Is Associated with Treatment Response and Survival in Patients with Relapsed or Refractory Non-Hodgkin Lymphoma Receiving CAR-T Cell Therapy
BibTeX
@article{kim2026prognostic,
title = {{Prognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy}},
author = {Woogyeom Kim and Moon-il Park and Jin Hee Na and In Ho Park and Sung Rok Kim and Yu-Ji Lee},
journal = {Renal Failure},
year = {2026},
month = nov,
doi = {10.1080/0886022x.2026.2755141},
url = {https://doi.org/10.1080/0886022x.2026.2755141},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Prognostic nutritional index is associated with clinical and histopathological severity in IgA nephropathy
AU - Woogyeom Kim
AU - Moon-il Park
AU - Jin Hee Na
AU - In Ho Park
AU - Sung Rok Kim
AU - Yu-Ji Lee
PY - 2026
DA - 2026/11/04
JO - Renal Failure
DO - 10.1080/0886022x.2026.2755141
UR - https://doi.org/10.1080/0886022x.2026.2755141
AB - Objective: The prognostic nutritional index (PNI) reflects immunonutritional status and serves as a prognostic marker in various diseases. However, its clinical significance in IgA nephropathy (IgAN) remains poorly understood. We investigated the association between PNI and clinico-pathological severity as well as long-term kidney outcomes in IgAN. Methods: We retrospectively analyzed 153 patients with biopsy-proven IgAN. Patients were categorized into four PNI groups (<40, 40–50 [reference], 50–55, and ≥55). The primary outcome was urine protein-to-creatinine ratio (UPCR) at biopsy; secondary outcomes were pathological severity (Oxford MEST-C and Haas classifications) and a composite kidney outcome (creatinine doubling, ≥40% eGFR decline, or dialysis initiation). Results: In the fully adjusted models, the lowest PNI group (<40) exhibited a 3.49-fold higher UPCR (AMR 3.49; p < 0.001) and was independently associated with segmental sclerosis (S1) (OR 5.09; p=0.029) and crescents (C1/2) (OR 3.81; p=0.031). Conversely, the highest PNI group (≥55) showed lower UPCR (AMR 0.47; p<0.001), reduced risk of advanced tubular atrophy/interstitial fibrosis (T1/2) (OR 0.31; p=0.042), and lower Haas stages (OR 0.29; p=0.010). Although the association with long-term outcomes was attenuated after UPCR adjustment in the total cohort, the lowest PNI group maintained a highly significant risk among patients with non-nephrotic range proteinuria (HR 17.99; p=0.006). Conclusion: PNI was associated with proteinuria and histological severity in IgAN and may provide additional prognostic information for long-term kidney outcomes beyond proteinuria alone, particularly in patients with non-nephrotic-range proteinuria.
SN - 0886-022X
SN - 1525-6049
ER -